These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17434095)

  • 41. Current diagnosis and management of symptomatic intracranial atherosclerotic disease.
    Prabhakaran S; Romano JG
    Curr Opin Neurol; 2012 Feb; 25(1):18-26. PubMed ID: 22143202
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antithrombotic medication for cardioembolic stroke prevention.
    Font MÀ; Krupinski J; Arboix A
    Stroke Res Treat; 2011; 2011():607852. PubMed ID: 21822469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stroke management.
    Warburton E; Alawneh JA; Clatworthy PL; Morris RS
    BMJ Clin Evid; 2011 Jun; 2011():. PubMed ID: 21658301
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The thrombomodulin analog Solulin promotes reperfusion and reduces infarct volume in a thrombotic stroke model.
    Su EJ; Geyer M; Wahl M; Mann K; Ginsburg D; Brohmann H; Petersen KU; Lawrence DA
    J Thromb Haemost; 2011 Jun; 9(6):1174-82. PubMed ID: 21645225
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Symptomatic intracranial arterial disease: incidence, natural history, diagnosis, and management.
    Vellimana AK; Ford AL; Lee JM; Derdeyn CP; Zipfel GJ
    Neurosurg Focus; 2011 Jun; 30(6):E14. PubMed ID: 21631215
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of acute ischemic stroke: beyond thrombolysis and supportive care.
    Shafi N; Kasner SE
    Neurotherapeutics; 2011 Jul; 8(3):425-33. PubMed ID: 21556680
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stenting versus medical treatment for severe symptomatic intracranial stenosis.
    Tang CW; Chang FC; Chern CM; Lee YC; Hu HH; Lee IH
    AJNR Am J Neuroradiol; 2011 May; 32(5):911-6. PubMed ID: 21393399
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Carotid artery disease and stenting: insights from recent clinical trials.
    Margey R; Drachman DE
    Curr Treat Options Cardiovasc Med; 2011 Apr; 13(2):129-45. PubMed ID: 21318556
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antiplatelet therapy in secondary stroke prevention--state of the art.
    Diener HC; Weimar C; Weber R
    J Cell Mol Med; 2010 Nov; 14(11):2552-60. PubMed ID: 20738444
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Production and validation of Putonghua- and Cantonese-Chinese language National Institutes of Health Stroke Scale training and certification videos.
    Cheung RT; Lyden PD; Tsoi TH; Huang Y; Liu M; Hon SF; Raman R; Liu L
    Int J Stroke; 2010 Apr; 5(2):74-9. PubMed ID: 20446940
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Stroke and atrial fibrillation].
    Gahn G
    Herzschrittmacherther Elektrophysiol; 2009 Jun; 20(2):70-2. PubMed ID: 19484179
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of atherosclerotic intracranial arterial stenosis.
    Turan TN; Derdeyn CP; Fiorella D; Chimowitz MI
    Stroke; 2009 Jun; 40(6):2257-61. PubMed ID: 19407238
    [No Abstract]   [Full Text] [Related]  

  • 53. [European Stroke Organisation 2008 guidelines for managing acute cerebral infarction or transient ischemic attack : part 2].
    Schellinger PD; Ringleb P; Hacke W
    Nervenarzt; 2008 Oct; 79(10):1180-4, 1186-8, 1190-201. PubMed ID: 18651119
    [No Abstract]   [Full Text] [Related]  

  • 54. [Anticoagulation for stroke prevention. An update].
    Koennecke HC
    Nervenarzt; 2007 Oct; 78(10):1124-9. PubMed ID: 17851645
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomised study.
    Wong KS; Chen C; Ng PW; Tsoi TH; Li HL; Fong WC; Yeung J; Wong CK; Yip KK; Gao H; Wong HB;
    Lancet Neurol; 2007 May; 6(5):407-13. PubMed ID: 17434095
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low-molecular-weight heparin and early neurologic deterioration in acute stroke caused by large artery occlusive disease.
    Wang Q; Chen C; Chen XY; Han JH; Soo Y; Leung TW; Mok V; Wong KS
    Arch Neurol; 2012 Nov; 69(11):1454-60. PubMed ID: 22893265
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low-molecular-weight heparin versus aspirin for acute ischemic stroke with large artery occlusive disease: subgroup analyses from the Fraxiparin in Stroke Study for the treatment of ischemic stroke (FISS-tris) study.
    Wang QS; Chen C; Chen XY; Han JH; Soo Y; Leung TW; Mok V; Wong KS
    Stroke; 2012 Feb; 43(2):346-9. PubMed ID: 22076004
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nadroparin plus aspirin versus aspirin alone in the treatment of acute ischemic stroke.
    Sarma GR; Roy AK
    Neurol India; 2003 Jun; 51(2):208-10. PubMed ID: 14571005
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.
    Greenhalgh J; Bagust A; Boland A; Martin Saborido C; Oyee J; Blundell M; Dundar Y; Dickson R; Proudlove C; Fisher M
    Health Technol Assess; 2011 Sep; 15(31):1-178. PubMed ID: 21888837
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke.
    Sandercock PA; Leong TS
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD000119. PubMed ID: 28374884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.